retatrutide clinical trial philippines Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation VisualAbstract: Retatrutide reduces body weight

It is important to distinguish between urinary changes related to GLP-1 therapy and those caused by other diabetes medications, particularly SGLT2 inhibitors (such as dapagliflozin, empagliflozin), which do directly increase urination as their primary mechanism of action

Coll, A

Frequently asked questions How does a GLP-1 change your water consumption

Major challenges in hydrogel-based delivery systems include difficulties with large-scale production, difficulties in precisely controlling gelation, the risk of immunogenicity, and the possibility of uneven drug distribution and retention within brain tissues

Resistance to leptin, the satiety hormone, is considered a prominent driver of obesity

Here are the side effects doctors say they see most often: Nausea or stomach cramps: By far the most common complaints, nausea and stomach cramps usually improve as your body adjusts to the medication, according to the Mayo Clinic